207 22. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation Between Kidney Function, Proteinuria, and Adverse Outcomes. JAMA. 2010;303(5):423-429. 10.1001/jama.2010.39 23. Nefrodata. Nefrovisie. Accessed Jan 2023. https://www.nefrovisie.nl/nefrodata/ 24. Academic Medical Center, Department of Medical Informatics. ERA-EDTA Registry Annual Report 2014. Amsterdam, the Netherlands. 2016. 25. Thio CHL, van Roon AM, Lefrandt JD, et al. Heart Rate Variability and Its Relation to Chronic Kidney Disease: Results From the PREVEND Study. Psychosom Med. 2018;80(3):307-316. 10.1097/PSY.0000000000000564 26. Van Blijderveen JC, Straus SM, Zietse R, et al. A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. Int Urol Nephrol. 2014;46(3):583-592. 10.1007/s11255-013-0563-3 27. Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1-184. 10.3310/hta14210 28. Hoefield R, Kalra P, Baker P, et al. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis. 2010;56(6):1072-1081. 10.1053/j.ajkd.2010.06.010 29. Mangen MJ, Bolkenbaas M, Huijts S, et al. Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L. Health Qual Life Outcomes. 2017;15(1):3. 10.1186/s12955016-0577-5 30. Liem Y, Bosch J, Hunink M. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11(4):733-741. 10.1111/j.1524-4733.2007.00308.x 31. Kanno A, Kikuya M, Ohkubo T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant. 2012;27(8):3218-3223. 10.1093/ndt/gfs054 32. Kim C, Kim B, Choi H, et al. Cumulative hypertension burden and risk of end-stage renal disease. Hypertens Res. 2021;44(12):1652-1661. 10.1038/s41440-021-00723-0 33. Annual figures for disorders - General practitioner registrations. Netherlands Institute for Health Care Research. Accessed Dec 2022. https://www.nivel.nl/nl/nivelzorgregistraties-eerste-lijn/jaarcijfers-aandoeningen-huisartsenregistraties 34. Public health and care information. National Institute for Health and Environment (RIVM). Accessed Dec 2022. https://www.vzinfo.nl/ 35. Cost of diseases 2019. National Institute for Health and Environment (RIVM). Accessed Dec 2022. https://statline.rivm.nl/ 36. Van Baal PHM, Wong A, Slobbe LCJ, et al. Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations. Pharmacoeconomics. 2011;29(3):175-187. 10.2165/11586130-000000000-00000 37. Dutch guideline for chronic kidney disease (CKD) [Nederlandse richtlijn chronische nierziekte]. Institute of the Federation of Medical Specialists [Federatie Medisch Specialisten]. Accessed Jan, 2023. https://richtlijnendatabase.nl/richtlijn/chronische_ nierschade_cns 38. National Health Service (NHS). Chronic Kidney Disease in England: The Human and Financial Cost. United Kingdom. 2017. Better Kidney Care for All. 39. Consumer price index. Statistics Netherlands (CBS). Accessed Dec 2022. https://www. cbs.nl/en-gb/figures/detail/83131eng 40. Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford University Press; 2006. 41. Schurer M, Matthijsse SM, Vossen CY, et al. Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands. Value Health. 2022;25(1):91-103. 10.1016/j.jval.2021.08.003 42. GBD Collaborative Network. Global Burden of Disease Study 2019 - Disability Weights. Seattle, USA. 2020. 43. Gurgel do Amaral M, Reijneveld SA, Almansa J, et al. Do Uncontrolled Hypertension, Diabetes, Dyslipidemia, and Obesity Mediate the Relationship Between Health Literacy and Chronic Kidney Disease Complications? Int J Environ Res Public Health. 2021;18(10):5235. 10.3390/ijerph18105235 44. Adarkwah CC, Gandjour A, Akkerman M, et al. To Treat or Not to Treat? CostEffectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective. Kidney Blood Press Res. 2013;37(2-3):168-180. 10.1159/000350142
RkJQdWJsaXNoZXIy MTk4NDMw